Worldwide retinopathy of prematurity (ROP) is a treatable disorder that is a leading cause of blindness in children.
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Worldwide retinopathy of prematurity (ROP) is a treatable disorder that is a leading cause of blindness in children. 1 ROP can usually be effectively treated if detected in the severe acute disease phase, but detection currently requires a series of resource-intensive examination by ophthalmologists with expertise in ROP. Less than 10 % of premature infants at risk (in the US defined as <1,500 g birth weight or gestational age 30 weeks or less or, if birth weight between 1,500 and 2,000 g, at the discretion of the neonatologist) require treatment. The largest and most recent of the studies was the telemedicine approaches for evaluating acute-phase ROP-e-ROP study. 5, 6 This large, multicenter observational study was conducted in 13 clinical centers in North America and enrolled 1,284 infants with birth weights <1,251 g.
The e-ROP study was designed to detect in digital retinal images those eyes with "referral-warranted" ROP (RW-ROP), defined as any stage of ROP in zone I, any stage 3 or worse ROP, or the presence of plus disease. 7 Disease of this severity was considered in need of an evaluation for a diagnostic examination by an ophthalmologist to determine whether treatment is indicated.
In the e-ROP study, infants with birth weights of <1,251 g, born in In summary, the e-ROP study results provide strong support for the validity of a telemedicine system to detect the presence of potentially serious ROP. The study successfully trained nonphysician imagers at the clinical centers to obtain images for remote grading and nonphysicians readers to grade those images reliably. It provides further evidence that telemedicine in ROP is a promising approach to providing excellent ROP screening in the US and other countries with well-developed neonatal intensive care unit (NICU) systems.
Since there is a limited supply of ophthalmologists available for ROP examinations, such an approach will allow physicians to examine only those most at-risk infants. One advantage of such a system is the ability to assess remotely the need for transferring an infant to another center where treatment can be given. In addition, the imaging session in a NICU need not be constrained by the ophthalmologist's schedule, but can be conducted at an optimal time for the infant.
In other regions of the world with developing NICU systems and a limited number of ophthalmologists available, providing a telemedicine system can increase the likelihood of detecting potentially serious ROP. This may be particularly important in countries with widely dispersed populations and a limited number of ophthalmologists.
Still there are a number of matters that need to be addressed as we consider telemedicine in ROP. We must deal with licensing and liability concerns for telemedicine and establish reliable and consistent grading of the images. Timely reporting of these time-sensitive gradings to the physicians caring for the at-risk infant must be expedited. The cost-effectiveness of such a technology is yet to be established. In addition, the best schedule and optimal frequency for imaging of an individual infant needs to be developed and tailoring such a schedule will likely include various risk factors such as birth weight, gestational age, postmenstrual age, and weight gain. Further, thus far level 1 telemedicine ROP studies have only dealt with the period during which the infant is in the NICU and not addressed when a child can be safely discharged from care. n
